Seungju Lee

Pusan National University Yangsan Hospital

Papers

Total Citations

H-Index

About

Dr. Seungju Lee is a clinician-researcher whose work centers on rare and aggressive breast cancer subtypes, with a particular focus on metaplastic breast cancer (MBC). His most cited study, a 2022 case report on male metaplastic breast cancer with poor prognosis, addresses a critical gap in oncology: MBC constitutes less than 1% of breast cancers and is even rarer in males, yet it is notoriously refractory to standard therapies. By documenting this case, Dr. Lee highlights the unique clinical challenges and aggressive nature of the disease, providing essential insights for diagnosis and treatment planning. Although his citation count is currently modest—reflecting the niche but vital nature of his work—his contribution is significant for its rarity and clinical relevance. Dr. Lee’s research underscores the importance of case-based evidence in advancing understanding of understudied malignancies, offering a foundation for future studies on MBC pathogenesis and therapeutic resistance. His dedication to illuminating these overlooked cases marks him as a valuable voice in the fight against aggressive breast cancers.